M1巨噬细胞来源外泌体通过调控NLRP3炎症小体激活促进脓毒症肠屏障功能障碍与焦亡
该研究探讨M1巨噬细胞来源外泌体(M1-Exos)在脓毒症肠屏障损伤中的作用。将回肠固有层巨噬细胞外泌体腹腔注射给健康小鼠,可致肠屏障受损、NLRP3炎症小体激活及肠上皮细胞焦亡;NEAT1在人M1-Exos和鼠M1-Exos中高表达。NEAT1敲除小鼠行盲肠结扎穿孔后仅出现轻度屏障损伤与NLRP3激活、无肠上皮细胞焦亡,补充M-M1-Exos后上述损伤再次加重;体外实验显示人M1-Exos致人肠上皮细胞屏障损伤和NLRP3介导的焦亡,缺乏NEAT1的外泌体则损伤不明显。外泌体NEAT1与NLRP3结合激活炎症小体,作者认为该通路为脓毒症肠屏障损伤提供了治疗靶点。
要点
- 盲肠结扎穿孔小鼠回肠固有层巨噬细胞表达M1标志物,其外泌体腹腔注射可致健康小鼠肠屏障受损、NLRP3炎症小体激活和肠上皮细胞焦亡。
- NEAT1在人M1-Exos和鼠M1-Exos中均高表达;NEAT1敲除小鼠盲肠结扎穿孔后仅轻度屏障损伤和NLRP3激活,无肠上皮细胞焦亡,补充M-M1-Exos后损伤再次加重。
- 体外用人M1-Exos处理人肠上皮细胞可致屏障损伤和NLRP3炎症小体介导的焦亡;暴露于缺乏NEAT1的外泌体时损伤不明显。
- 外泌体NEAT1与NLRP3结合以激活NLRP3炎症小体;作者认为肠道M1巨噬细胞分泌的外泌体NEAT1是脓毒症肠屏障损伤的潜在治疗靶点。
适用人群与场景
- 实验对象为健康小鼠(腹腔注射外泌体)、盲肠结扎穿孔小鼠及NEAT1敲除小鼠,以及体外培养的人肠上皮细胞和人单核细胞来源巨噬细胞;非临床患者研究。
研究设计与关键结果
- 研究类型为动物实验与体外实验:将回肠固有层巨噬细胞来源外泌体腹腔注射健康小鼠,评估肠屏障、NLRP3炎症小体及肠上皮细胞焦亡。
- 盲肠结扎穿孔小鼠回肠固有层巨噬细胞表达M1标志物;注射鼠M1-Exos(M-M1-Exos)致小鼠肠屏障受损、NLRP3炎症小体激活和肠上皮细胞焦亡。
- NEAT1在人M1-Exos和M-M1-Exos中均高表达;NEAT1敲除小鼠盲肠结扎穿孔后仅轻度屏障损伤和NLRP3炎症小体激活、无肠上皮细胞焦亡,补充注射M-M1-Exos后损伤再次加重。
- 体外用人M1-Exos处理人肠上皮细胞致屏障损伤和NLRP3炎症小体介导的焦亡;暴露于缺乏NEAT1的外泌体时损伤不明显。
- RNA pull-down和RNA结合蛋白免疫沉淀显示外泌体NEAT1与NLRP3结合以激活NLRP3炎症小体。
证据类型、等级与局限
- 证据类型为动物实验与体外实验;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为肠道M1巨噬细胞分泌的外泌体NEAT1通过激活NLRP3炎症小体促进肠上皮细胞焦亡,为脓毒症肠屏障损伤提供了治疗靶点;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intestinal barrier injury is pivotal in sepsis deterioration. M1 macrophage-derived exosomes (M1-Exos) promote gut inflammation. We aimed to reveal the roles of M1-Exos in sepsis-induced gut barrier injury and underlying mechanisms.
METHODS: Exosomes from ileum lamina propria macrophages were intraperitoneally injected into healthy mice to evaluate the impacts on intestinal barrier, NLRP3 inflammasome, and intestinal epithelial cells (IECs) pyroptosis. Long noncoding RNA NEAT1 was detected in mouse lamina propria macrophages and human monocyte-derived macrophages, as well as these macrophage-derived exosomes. The functions of NEAT1 were further investigated using gene knockout mice and in vitro experiments. The potential interaction between NEAT1 and NLRP3 was assessed via RNA pull-down and RNA-binding protein immunoprecipitation.
RESULTS: Ileum lamina propria macrophages from cecal ligation and puncture mice expressed M1 biomarkers. Mice M1-Exos (M-M1-Exos) injection caused barrier impairment, NLRP3 inflammasome activation and IECs pyroptosis. NEAT1 is highly expressed in both human M1-Exos and M-M1-Exos. In NEAT1 knockout mice, cecal ligation and puncture only caused slight barrier impairment and NLRP3 inflammasome activation without IECs pyroptosis, which were again aggravated by supplementary M-M1-Exos injection. In vitro , treating human IEC with human M1-Exos-caused barrier damage and NLRP3 inflammasome-mediated pyroptosis. These impairments were inapparent when human IEC was exposed to exosomes that lacked NEAT1 . Moreover, exosomal NEAT1 combined with NLRP3 to activate the NLRP3 inflammasome.
CONCLUSION: These findings revealed that gut-resident M1 macrophages secreted exosomal NEAT1 to promote IECs pyroptosis via activating NLRP3 inflammasome, which provided a therapeutic target for septic gut barrier injury.
参考来源
- Yang T, Wang Z, Wu H, et al. M1 Macrophage-Derived Exosomes Promote Intestinal Barrier Dysfunction and Pyroptosis in Sepsis by Modulating NLRP3 Inflammasome Activation. Shock. 2026. PMID: 42008763. doi:10.1097/SHK.0000000000002825
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。